← All Bone Biologics CORP filings

Bone Biologics CORP Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
BBLG
Bone Biologics CORP
SCHEDULE: Intracoastal Capital Discloses 9.99% Stake in Bone Biologics
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a 9.99% beneficial ownership stake in Bone Biologics Corporation as of September 30, 2025.
NASDAQ
BBLG
Bone Biologics CORP
SCHEDULE: Intracoastal Capital and Affiliates Report 9.99% Stake in Bone Biologics Corporation
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has reported a 9.99% beneficial ownership stake in Bone Biologics Corporation's common stock as of July 3, 2025.